A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Viewers are urged to contact these profiles privately for supplier links, while also receiving discount codes.
Thriving Commerce on Social Networks
Additionally, a robust market exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to other platforms for purchases.
Learning About Retatrutide
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Experts Express Concerns
However, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin.
Some professionals stated the popularity for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Response and Content Removal
Based on the social media company, the platform has removed problematic content and banned associated hashtags and search suggestions. The organization said it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Research also found communities with up to nine thousand members marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of users, filled with photos of weight loss, positive testimonials and detailed instructions for mixing or injecting at residence.
Within minutes of entering one community, a vendor shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.
Item Information and Costs
Within these groups, messages show black plastic packages with postal service stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens usually priced at £160 for 20mg. When questioned how long a pen should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service said it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering materials they can’t verify. Even if the science behind this drug is valid, these online products may not include what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has previously encountered individuals injured by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to potentially significant health risks”.
